> The Issue Reflecting both sides of the challenge, our clients have required guidance to monitor and mitigate the threats to their biologics businesses, while also needing rapid decision-making support to evaluate their potential entry into the biosimilars market.
> Our Approach Following secondary and primary research, our consultants managed a cross-functional client team at a major biotech to prioritize the most effective elements of its biosimilar defence strategy. For a Japanese client considering investment in the biosimilars markets, we conducted rigorous secondary research and intensive evaluations across multiple work streams to deliver robust understanding of local market drivers.
> The Result Our biotech client benefited from a multiscenario impact model and decision support matrix that enabled them to plan for the impact of biosimilars on their business in nine individual markets. In Japan, our client adjusted their biosimilars entry strategy, based on our timely coverage and synthesis of local market insights.
> The Issue A large pharma client sought to understand how the introduction of personalized healthcare (PHC) affects the commercial performance of drugs launching into, or already on, the market.
> Our Approach Through in-depth secondary market research, detailed quantitative case study analysis, and primary interviews with internal and external experts, we were able to identify the key market factors determining whether PHC has a positive or negative impact upon a pharmaceutical product.
> The Result A PHC checklist of actions was developed along with an exhaustive report including ‘actions to imitate and to avoid’. The client used our report and quantitative model to inform their broader organization about the impact of PHC on drug sales across classes or disease areas.
Datamonitor Healthcare is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with
them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and
Wales. Number 8860726